A retrospective study assessing the role of Pasireotide administration after pancreatectomy in reducing the outcome of clinically relevant Postoperative pancreatic fistula with stratification by fistula risk score
Latest Information Update: 25 Aug 2020
At a glance
- Drugs Pasireotide (Primary)
- Indications Digestive system fistula; Pancreatic disorders
- Focus Therapeutic Use
- 25 Aug 2020 New trial record
- 01 Aug 2020 Results published in the Journal of Surgical Oncology